This Biotech stock is likely to be a HUGE winner this year
Updated
A minimum expected target is 60% ROI ($6 per share). A multi-bagger is definitely in the cards as it historically returned several x from its previous bottoms in 2000 and 2008/2009.
Comment
Bullish structure still intact ... earnings release in two days. Technical structure continues to suggest major upside is more likely.Comment
Major rally since yesterdayComment
Massive failed breakout. I got lucky to get out at a small lose just under my average cost of 3.25. Situations like these should constantly remind us why risk management is so crucial to success as a trader.Trade closed: stop reached
loss*Trade active
Re-entered at 3.85 and added at 4.15. The key with this trade from here is it coming to fruition quickly. 
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.